Eyes on New Product Development

Abstract

View all access options for this article.

Novack

G.D.

Pipeline: the accelerated drug approval. Ocul. Surf. 8:205–207, 2010.

Kubota

, Calkins

D.J

, Henry

S.H.

, and Linsenmeier

R.A.

Emixustat reduces metabolic demand of dark activity in the retina. Invest. Ophthalmol. Vis. Sci. 60:4924–4930, 2019.

Silbiger

N.J.

, and Stubler

A.D.

Unprofessional peer reviews disproportionately harm underrepresented groups in STEM. Peer J. 7:e8247, 2019.

Gottlieb

Price controls would stifle biotech innovation. WSJ. December 11, 2019.

Cohen

P.A.

, and Bass

Injecting safety into supplements—modernizing the dietary supplement law. N. Engl. J. Med. 381:2387–2389, 2019.